Johnson & Johnson to Invest Over $1 Billion in Pennsylvania Cell Therapy Manufacturing Facility
Johnson & Johnson (JNJ) has announced an investment of more than $1 billion to build a next-generation cell therapy manufacturing facility in Montgomery County, Pennsylvania.
Pharma USA | 20/02/2026 | By Darshana | 139
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy